Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

New formulations of carteolol may reduce dosing frequency

May 2, 2000

IOP-lowering efficacy of anecortave established in preclinical models and in patients

May 2, 2000

AMPA antagonist improves visual function in humans

May 2, 2000

New chemical class with dual mechanism of action presented as promising glaucoma therapeutics

May 2, 2000

ADL-2-1294 licensed to Santen for ophthalmic indications

April 28, 2000

CPMP recommends European approval of Visudyne for wet AMD

April 19, 2000

FDA approves Visudyne therapy for treatment of AMD

April 13, 2000

Interferon alfa-2b offers protection from eye involvement in Behcet's disease

April 13, 2000

New ocular antibiotic enters the pipeline at InSite Vision

April 12, 2000

Gilead licenses NX-1838, a new AMD treatment, to EyeTech

April 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...